Annual Revenue and Adjusted EBITDA Improve by 50%
TORONTO, March 27, 2024 /CNW/ - MediPharm Labs Corp. (TSX:LABS.TO) (OTC-BB:MEDIF) (FSE:MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended December 31, 2023.
Read more at newswire.ca